ReP USP - Resultado da busca

Artigo de periodico
Pilot study of treatment of patients with deep infiltrative endometriosis with methotrexate carried in lipid nanoparticles (2024)
Tavares, Roberta Avila; Gibran, Luciano; Brito, Luiz Gustavo Oliveira; Tavoni, Thauany Martins ; Gonçalves, Manoel Orlando; Baracat, Edmund Chada; Maranhão, Raul Cavalcante ; Podgaec, Sérgio
Source: Archives of Gynecology and Obstetrics. Unidades: FM, FCF
Subjects: ENDOMETRIOSE, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Roberta Avila et al. Pilot study of treatment of patients with deep infiltrative endometriosis with methotrexate carried in lipid nanoparticles. Archives of Gynecology and Obstetrics, v. 309, p. 659–667, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s00404-023-07246-8. Acesso em: 06 nov. 2024.
APA
Tavares, R. A., Gibran, L., Brito, L. G. O., Tavoni, T. M., Gonçalves, M. O., Baracat, E. C., et al. (2024). Pilot study of treatment of patients with deep infiltrative endometriosis with methotrexate carried in lipid nanoparticles. Archives of Gynecology and Obstetrics, 309, 659–667. doi:10.1007/s00404-023-07246-8
NLM
Tavares RA, Gibran L, Brito LGO, Tavoni TM, Gonçalves MO, Baracat EC, Maranhão RC, Podgaec S. Pilot study of treatment of patients with deep infiltrative endometriosis with methotrexate carried in lipid nanoparticles [Internet]. Archives of Gynecology and Obstetrics. 2024 ; 309 659–667.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.1007/s00404-023-07246-8
Vancouver
Tavares RA, Gibran L, Brito LGO, Tavoni TM, Gonçalves MO, Baracat EC, Maranhão RC, Podgaec S. Pilot study of treatment of patients with deep infiltrative endometriosis with methotrexate carried in lipid nanoparticles [Internet]. Archives of Gynecology and Obstetrics. 2024 ; 309 659–667.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.1007/s00404-023-07246-8
Artigo de periodico
Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study (2024)
Marinho, Lucas Lage; Rached, Fabiana Hanna ; Morikawa, Aleksandra Tiemi ; Tavoni, Thauany Martins ; Cardoso, Ana Paula Toniello; Torres, Roberto Vitor Almeida; Assunção Junior, Antonildes Nascimento; Serrano Junior, Carlos Vicente ; Nomura, Cesar Higa ; Maranhão, Raul Cavalcante
Source: Frontiers in Cardiovascular Medicine. Unidades: FM, FCF, ICB
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES, INFLAMAÇÃO, INTERLEUCINA 6
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARINHO, Lucas Lage et al. Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study. Frontiers in Cardiovascular Medicine, v. 11, p. 1-9, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fcvm.2024.1342832. Acesso em: 06 nov. 2024.
APA
Marinho, L. L., Rached, F. H., Morikawa, A. T., Tavoni, T. M., Cardoso, A. P. T., Torres, R. V. A., et al. (2024). Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study. Frontiers in Cardiovascular Medicine, 11, 1-9. doi:10.3389/fcvm.2024.1342832
NLM
Marinho LL, Rached FH, Morikawa AT, Tavoni TM, Cardoso APT, Torres RVA, Assunção Junior AN, Serrano Junior CV, Nomura CH, Maranhão RC. Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study [Internet]. Frontiers in Cardiovascular Medicine. 2024 ; 11 1-9.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.3389/fcvm.2024.1342832
Vancouver
Marinho LL, Rached FH, Morikawa AT, Tavoni TM, Cardoso APT, Torres RVA, Assunção Junior AN, Serrano Junior CV, Nomura CH, Maranhão RC. Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study [Internet]. Frontiers in Cardiovascular Medicine. 2024 ; 11 1-9.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.3389/fcvm.2024.1342832
Trabalho de evento-resumo periodico
Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts (2023)
Gatto, Mariana ; Mota, Gustavo Augusto Ferreira ; Borim, Patrícia Aparecida ; Santos, A. C. C; Pagan, Luana Urbano ; Souza, L. M; Rodrigues, E. A; Silva, R. C. F; Oliveira, J. P. G; Meirelles, A. L. B; Brosler, Jessica Yumi ; Maranhão, Raul Cavalcante ; Zornoff, Leonardo Antônio Mamede ; Okoshi, Katashi ; Okoshi, Marina Politi
Source: European Heart Journal. Conference titles: European Society of Cardiology Congress/ESC. Unidade: FCF
Subjects: METOTREXATO, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GATTO, Mariana et al. Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts. European Heart Journal. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.3097/7390939. Acesso em: 06 nov. 2024. , 2023
APA
Gatto, M., Mota, G. A. F., Borim, P. A., Santos, A. C. C., Pagan, L. U., Souza, L. M., et al. (2023). Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts. European Heart Journal. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.3097/7390939
NLM
Gatto M, Mota GAF, Borim PA, Santos ACC, Pagan LU, Souza LM, Rodrigues EA, Silva RCF, Oliveira JPG, Meirelles ALB, Brosler JY, Maranhão RC, Zornoff LAM, Okoshi K, Okoshi MP. Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts [Internet]. European Heart Journal. 2023 ; 44( p.):[citado 2024 nov. 06 ] Available from: https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.3097/7390939
Vancouver
Gatto M, Mota GAF, Borim PA, Santos ACC, Pagan LU, Souza LM, Rodrigues EA, Silva RCF, Oliveira JPG, Meirelles ALB, Brosler JY, Maranhão RC, Zornoff LAM, Okoshi K, Okoshi MP. Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts [Internet]. European Heart Journal. 2023 ; 44( p.):[citado 2024 nov. 06 ] Available from: https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.3097/7390939
Artigo de periodico
Intraoperative paclitaxel associated with lipid nanoparticles in trabeculectomy (2023)
Occhiutto, Marcelo L; Passos, Thais H. M; Freitas, Fatima R. de; Maranhão, Raul Cavalcante ; Costa, Vital P
Source: Clinical and Experimental Ophthalmology. Unidade: FCF
Subjects: NANOPARTÍCULAS, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OCCHIUTTO, Marcelo L et al. Intraoperative paclitaxel associated with lipid nanoparticles in trabeculectomy. Clinical and Experimental Ophthalmology, v. 51, n. 6, p. 644-646, 2023Tradução . . Acesso em: 06 nov. 2024.
APA
Occhiutto, M. L., Passos, T. H. M., Freitas, F. R. de, Maranhão, R. C., & Costa, V. P. (2023). Intraoperative paclitaxel associated with lipid nanoparticles in trabeculectomy. Clinical and Experimental Ophthalmology, 51( 6), 644-646.
NLM
Occhiutto ML, Passos THM, Freitas FR de, Maranhão RC, Costa VP. Intraoperative paclitaxel associated with lipid nanoparticles in trabeculectomy. Clinical and Experimental Ophthalmology. 2023 ; 51( 6): 644-646.[citado 2024 nov. 06 ]
Vancouver
Occhiutto ML, Passos THM, Freitas FR de, Maranhão RC, Costa VP. Intraoperative paclitaxel associated with lipid nanoparticles in trabeculectomy. Clinical and Experimental Ophthalmology. 2023 ; 51( 6): 644-646.[citado 2024 nov. 06 ]
Artigo de periodico
Use of paclitaxel associated to lipid core nanoparticles (LDE) in the second or third line treatment of advanced pancreatic adenocarcinoma (2023)
Bighetti, Bruna; Donnarumma, Carlos Del Cistia; Esper, Rodrigo Barbosa; Vital, Carolina Graziani; Morikawa, Aleksandra Tiemi; Oliveira, José Salvador Rodrigues de; Maranhão, Raul Cavalcante ; Forones, Nora Manoukian
Source: Journal of Oncology Research and Therapy. Unidade: FCF
Subjects: ADENOCARCINOMA, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIGHETTI, Bruna et al. Use of paclitaxel associated to lipid core nanoparticles (LDE) in the second or third line treatment of advanced pancreatic adenocarcinoma. Journal of Oncology Research and Therapy, v. 8, p. 1-7 art. 10192, 2023Tradução . . Disponível em: https://dx.doi.org/10.29011/2574-710X.10192. Acesso em: 06 nov. 2024.
APA
Bighetti, B., Donnarumma, C. D. C., Esper, R. B., Vital, C. G., Morikawa, A. T., Oliveira, J. S. R. de, et al. (2023). Use of paclitaxel associated to lipid core nanoparticles (LDE) in the second or third line treatment of advanced pancreatic adenocarcinoma. Journal of Oncology Research and Therapy, 8, 1-7 art. 10192. doi:10.29011/2574-710X.10192
NLM
Bighetti B, Donnarumma CDC, Esper RB, Vital CG, Morikawa AT, Oliveira JSR de, Maranhão RC, Forones NM. Use of paclitaxel associated to lipid core nanoparticles (LDE) in the second or third line treatment of advanced pancreatic adenocarcinoma [Internet]. Journal of Oncology Research and Therapy. 2023 ; 8 1-7 art. 10192.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.29011/2574-710X.10192
Vancouver
Bighetti B, Donnarumma CDC, Esper RB, Vital CG, Morikawa AT, Oliveira JSR de, Maranhão RC, Forones NM. Use of paclitaxel associated to lipid core nanoparticles (LDE) in the second or third line treatment of advanced pancreatic adenocarcinoma [Internet]. Journal of Oncology Research and Therapy. 2023 ; 8 1-7 art. 10192.[citado 2024 nov. 06 ] Available from: https://dx.doi.org/10.29011/2574-710X.10192
Trabalho de evento-resumo periodico
LDE-paclitaxel in second or later lines in advanced pancreatic cancer: a phase I trial (2023)
Bighetti, Bruna; Maranhão, Raul Cavalcante ; Forones, Nora Manoukian
Source: Journal of Clinical Oncology. Conference titles: American Society Clinical Oncology/ASCO. Unidade: FCF
Subjects: NANOPARTÍCULAS, QUIMIOTERAPIA, NEOPLASIAS PANCREÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIGHETTI, Bruna e MARANHÃO, Raul Cavalcante e FORONES, Nora Manoukian. LDE-paclitaxel in second or later lines in advanced pancreatic cancer: a phase I trial. Journal of Clinical Oncology. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.e16298?role=tab. Acesso em: 06 nov. 2024. , 2023
APA
Bighetti, B., Maranhão, R. C., & Forones, N. M. (2023). LDE-paclitaxel in second or later lines in advanced pancreatic cancer: a phase I trial. Journal of Clinical Oncology. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.e16298?role=tab
NLM
Bighetti B, Maranhão RC, Forones NM. LDE-paclitaxel in second or later lines in advanced pancreatic cancer: a phase I trial [Internet]. Journal of Clinical Oncology. 2023 ; 41( 16):[citado 2024 nov. 06 ] Available from: https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.e16298?role=tab
Vancouver
Bighetti B, Maranhão RC, Forones NM. LDE-paclitaxel in second or later lines in advanced pancreatic cancer: a phase I trial [Internet]. Journal of Clinical Oncology. 2023 ; 41( 16):[citado 2024 nov. 06 ] Available from: https://ascopubs.org/doi/pdf/10.1200/JCO.2023.41.16_suppl.e16298?role=tab

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Non normalized affiliation